IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...

Revenue: RM1.35b (down 8.6% from FY 2024). Net income: RM218.7m (down 27% from FY 2024). Profit margin: 16% (down from 20% in FY 2024). The decrease in margin was driven by lower revenue. EPS: RM0.058 ...

A Boston-based biotech company with large operations in Indiana has closed on a $103 million funding raise, bringing its cumulative fundraising to more than a half-billion dollars for the ...

IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...

Revenue: RM1.48b (up 9.2% from FY 2023). Net income: RM300.2m (down 7.2% from FY 2023). Profit margin: 20% (down from 24% in FY 2023). The decrease in margin was driven by higher expenses. EPS: RM0.08 ...

Inari Medical will host a conference call to discuss the fourth quarter and full year 2022 financial results after market close on Monday, February 27, 2023 at 1:30 p.m. Pacific Time / 4:30 p.m.

Generated revenue of $107.8 million in the fourth quarter of 2022, up 12% sequentially and 30% over the same quarter last year, and finished full year 2022 with revenue of $383.5 million, a 38% ...